Legacy Healthcare's CINAINU® Receives FDA Breakthrough Therapy Designation for Alopecia Areata in Adults, Adolescents and Children Aged 2 Years and Older
EPALINGES, Switzerland, Oct. 13, 2026 /PRNewswire/ -- Legacy Healthcare, a biopharmaceutical company developing innovative botanical prescription drugs, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to CINAINU® (LH-8), its...
Covered in this story
What has happened since
- Labcorp is up 3.1% since this was published, 7 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $LH yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Labcorp →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.